Cargando…

New-onset Graves’ disease following SARS-CoV-2 vaccination: a case report

A 22-year-old male with a history of ulcerative colitis and nephrotic syndrome treated with immunomodulatory agents including vedolizumab and mycophenolic acid developed hyperthyroidism 2 weeks following the first administration of BNT162b2 vaccine (Pfizer-BioNTech COVID-19 vaccine). Graves’ disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manta, Ringo, Martin, Charlotte, Muls, Vinciane, Poppe, Kris G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346333/ https://www.ncbi.nlm.nih.gov/pubmed/35900872 http://dx.doi.org/10.1530/ETJ-22-0049

Ejemplares similares

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

A case report of new onset graves’ disease induced by SARS-CoV-2 infection or vaccine?
por: Hamouche, Walid, et al.
Publicado: (2022)

Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
por: Weintraub, Michael A., et al.
Publicado: (2021)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)

Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection
por: Harris, Asaf, et al.
Publicado: (2020)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination
por: Patrizio, Armando, et al.
Publicado: (2021)

Graves‘ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
por: Triantafyllidis, Konstantinos Katsikas, et al.
Publicado: (2022)

Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination
por: Patrizio, Armando, et al.
Publicado: (2022)

Graves’ orbitopathy post-SARS-CoV-2 vaccines: report on six patients
por: Abeillon-du Payrat, J., et al.
Publicado: (2022)

POS-134 NEW ONSET NEPHROTIC SYNDROME FOLLOWING INACTIVATED SARS-CoV-2 VACCINE
por: Lim, Y.S., et al.
Publicado: (2022)

Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
por: Rigamonti, C., et al.
Publicado: (2022)

Graves’ Disease Caused by SARS-CoV-2 Infection
por: Sousa, Bruno, et al.
Publicado: (2022)

Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection
por: Liu, Ya, et al.
Publicado: (2021)

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review
por: Holzer, Marie-Therese, et al.
Publicado: (2022)

An Exceptional Cause of Increased (18)F-Fluorodeoxyglucose Uptake on PET/CT in a Thyroid Nodule
por: Manta, Ringo, et al.
Publicado: (2023)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

A Case of Graves’ Disease Following Vaccination with the Oxford-AstraZeneca SARS-CoV-2 Vaccine: Case Report and Review of the Literature
por: Cuenca, Dalia, et al.
Publicado: (2022)

Recurrent Graves’ disease post SARS-CoV-2 infection
por: Montebello, Annalisa
Publicado: (2021)

New-onset ocular myasthenia gravis following SARS-CoV-2 infection
por: Banerjee, Prabrisha, et al.
Publicado: (2022)

A Large Cluster of New Onset Autoimmune Myositis in the Yorkshire Region Following SARS-CoV-2 Vaccination
por: De Marco, Gabriele, et al.
Publicado: (2022)

Two further cases of Graves’ disease following SARS-Cov-2 vaccination
por: Zettinig, G., et al.
Publicado: (2021)

Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
por: Avci, Enver, et al.
Publicado: (2021)

Miopatía asociada a infección grave por SARS-CoV-2
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

Graves’ disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature
por: Takedani, Kai, et al.
Publicado: (2023)

New-Onset Systemic Lupus Erythematosus after mRNA SARS-CoV-2 Vaccination
por: Báez-Negrón, Laisha, et al.
Publicado: (2022)

Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased
por: Diebold, Matthias, et al.
Publicado: (2022)

New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
por: Ma, Qiqi, et al.
Publicado: (2022)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
por: Showers, Christopher R, et al.
Publicado: (2022)

Relapse of Graves' disease following SARS-CoV-2 infection: A case report and brief literature review
por: Mohammed, Saeed Rashaad, et al.
Publicado: (2021)

Sweet Syndrome Following SARS-CoV2 Vaccination
por: Baffa, Maria Efenesia, et al.
Publicado: (2021)

Impaired hearing following SARS-CoV-2 vaccinations
por: Finsterer, Josef, et al.
Publicado: (2022)

Autoimmune phenomena following SARS-CoV-2 vaccination
por: Ishay, Yuval, et al.
Publicado: (2021)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Gross Hematuria following SARS-CoV-2 Vaccination
por: Sattari, Maryam, et al.
Publicado: (2023)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
por: Antuña, Victoria Lobo, et al.
Publicado: (2023)

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
por: Watad, Abdulla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1srgcatuv6co4oqk4i4sravgn